Literature DB >> 29741766

Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.

M R Wehner1, N Dalma2, C Landefeld3, A Pare-Anastasiadou2,4, I Koutelidas2, M M Chren5,6, N Aji7, C E Teng8, B A Koenig6,9, J Tang10, K Covinsky6, E Linos6.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29741766      PMCID: PMC6141323          DOI: 10.1111/bjd.16730

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Daniel Berg; Glen M Bowen; Richard T Cheney; Gregory A Daniels; L Frank Glass; Roy C Grekin; Kenneth Grossman; Susan A Higgins; Alan L Ho; Karl D Lewis; Daniel D Lydiatt; Kishwer S Nehal; Paul Nghiem; Elise A Olsen; Chrysalyne D Schmults; Aleksandar Sekulic; Ashok R Shaha; Wade L Thorstad; Malika Tuli; Marshall M Urist; Timothy S Wang; Sandra L Wong; John A Zic; Karin G Hoffmann; Anita Engh
Journal:  J Natl Compr Canc Netw       Date:  2016-05       Impact factor: 11.908

Review 2.  The Epidemiology and Clinicopathological Features of Basal Cell Carcinoma in Patients 80 Years and Older: A Systematic Review.

Authors:  Satish F K Lubeek; Lieke J van Vugt; Katja K H Aben; Peter C M van de Kerkhof; Marie-Jeanne P Gerritsen
Journal:  JAMA Dermatol       Date:  2017-01-01       Impact factor: 10.282

3.  Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy.

Authors:  Eleni Linos; Steven A Schroeder; Mary-Margaret Chren
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

4.  Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.

Authors:  Mary-Margaret Chren; Jeanette S Torres; Sarah E Stuart; Daniel Bertenthal; Remedios J Labrador; W John Boscardin
Journal:  Arch Dermatol       Date:  2011-05

5.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

6.  Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.

Authors:  Eleni Linos; Rupa Parvataneni; Sarah E Stuart; W John Boscardin; C Seth Landefeld; Mary-Margaret Chren
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

7.  Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?

Authors:  Eleni Linos; Mary-Margaret Chren; Irena Stijacic Cenzer; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2016-06-15       Impact factor: 5.562

  7 in total
  4 in total

1.  Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms.

Authors:  A Dascalu; B N Walker; Y Oron; E O David
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-21       Impact factor: 4.322

2.  Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.

Authors:  Eleni Linos; Mary-Margaret Chren
Journal:  JAMA Intern Med       Date:  2021-08-01       Impact factor: 44.409

Review 3.  Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.

Authors:  Brian C Baumann; Kelly M MacArthur; Jerry D Brewer; William M Mendenhall; Christopher A Barker; Jeremy R Etzkorn; Nathaniel J Jellinek; Jeffrey F Scott; Hiram A Gay; John C Baumann; Farrin A Manian; Phillip M Devlin; Jeff M Michalski; Nancy Y Lee; Wade L Thorstad; Lynn D Wilson; Carlos A Perez; Christopher J Miller
Journal:  Cancer       Date:  2020-06-01       Impact factor: 6.860

4.  Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.

Authors:  James M Kilgour; Aatman Shah; Nicole M Urman; Shaundra Eichstadt; Hanh N Do; Irene Bailey; Amar Mirza; Shufeng Li; Anthony E Oro; Sumaira Z Aasi; Kavita Y Sarin
Journal:  Clin Cancer Res       Date:  2021-08-06       Impact factor: 12.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.